جست‌وجوی استاد و پژوهشگر

Vasso Anagnostopoulouمشاهده پروفایل

پژوهشگر ارشد

• Medical Statistics
• Clinical Trials Methodology
• Global Health
• +۵ مورد دیگر

Dr. Vasso Anagnostopoulou is a Senior Research Fellow in Medical Statistics at the Brighton and Sussex Medical School (BSMS), working within the Department of Primary Care & Public Health. She is actively affiliated with multiple research units including the NIHR Global Health Research Unit for Neglected Tropical Diseases, the NIHR Social Sciences for Severe Stigmatising Skin Conditions (5S) Foundation, and the Brighton & Sussex Clinical Trials Unit where she serves as statistician for the REDUCe 2 and Chelsea II trials. Her career spans both pure mathematics and applied medical statistics, reflecting a unique interdisciplinary trajectory. Dr. Anagnostopoulou's educational background demonstrates her interdisciplinary journey: BSc (Hons) and MSc in Mathematics from the University of Warwick, PhD in Mathematics (Dynamical Systems) from Queen Mary University of London, followed by postdoctoral positions at TU Dresden, Imperial College London (as a Marie Curie Intra-European Fellow), and Queen Mary University of London. In 2023, she completed an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, marking her transition to applied medical research. Her research spans two distinct but complementary domains: mathematical theory (particularly dynamical systems) and medical statistics applied to global health. She focuses on neglected tropical diseases (especially podoconiosis), with significant work in hepatology (cirrhosis management) and cardiology (thoracic aortic aneurysms). Her recent publications demonstrate a clear shift from pure mathematics to applied medical research, with an emphasis on implementation science, clinical trials methodology, and health outcomes in global health contexts. She has co-authored numerous high-impact studies in journals like BMC Medicine and PLoS Neglected Tropical Diseases. Dr. Anagnostopoulou actively contributes to major clinical trials and implementation research projects, particularly in Ethiopia. Her work addresses critical gaps in healthcare for neglected populations, focusing on stigma reduction, community interventions, and cost-effective care packages. As a statistician on multiple NIHR-funded projects, she plays a crucial role in designing robust studies and analyzing complex health data from diverse global settings. She serves as a joint supervisor for research projects, including 'Assessing the Health and Economic Burden of podoconiosis in Rwanda,' and is involved in mentoring the next generation of global health researchers. Her dual expertise in advanced mathematics and medical statistics positions her as a valuable collaborator who can bridge theoretical rigor with practical healthcare applications in resource-limited settings.

Heather Himburgمشاهده پروفایل

استاد

• Radiation Biology
• Cancer Stem Cell Biology
• Hematopoiesis
• +۲ مورد دیگر

Heather Himburg, PhD, serves as Professor in the Department of Radiation Oncology at the Medical College of Wisconsin (MCW), where her research focuses on radiation biology and therapeutic development for radiation injury mitigation. Her work bridges translational science and clinical applications in radiation oncology. Education: PhD in Biomedical Engineering, Duke University, 2005 MS in Biomedical Engineering, Ohio State University, 2001 BS in Physics, Miami University, 1998 Research Focus: Dr. Himburg's laboratory investigates acute and delayed radiation effects on multiple organ systems, with specialization in vascular injury mechanisms and bone marrow microenvironment dynamics. Her team develops countermeasures for hematopoietic acute radiation syndrome and studies cancer stem cell biology to improve radiation therapy safety. Current projects target radioprotective therapeutics for bone marrow, heart, lung, and kidney tissues using preclinical models established by MCW emeritus researchers Meetha Medhora and John Moulder. Publication Analysis: Her 2024-2025 publications reveal dominant themes in head and neck cancer therapeutics, radiation-induced organ toxicity, and immune modulation. Key trends include molecular radiosensitization strategies (CXCL12 pathways), advanced imaging for treatment response monitoring, and novel countermeasures for radiation syndromes. The work consistently integrates translational approaches from in vitro models to rodent studies, emphasizing clinical applicability in radiation oncology. Laboratory Structure: The Himburg Laboratory (MFRC 4072/4004 lab, 4076 office) operates as a collaborative hub with Brian Fish directing the Precision Irradiation Core. The team comprises research scientists, technologists, and coordinators specializing in vascular biology, stem cell assays, and radiation countermeasure development, supporting MCW's radiation oncology research infrastructure through the ROCKET Program.

Isabelle Brunetمشاهده پروفایل

پژوهشگر

• Neurovascular Interactions
• Neuroscience
• Vascular Biology
• +۳ مورد دیگر

Isabelle Brunet is a leading neuroscientist and vascular biologist holding a permanent Inserm research position (ranked 1st) at the Interdisciplinary Center for Research in Biology (CIRB) of the Collège de France in Paris. She directs an 8-member research team investigating neurovascular interactions in development and disease using transgenic mouse/fish models, molecular approaches, and 3D-imaging techniques. Her educational foundation includes a PhD in neuroscience under Alain Prochiantz and Christine Holt focusing on axon guidance in the visual system, followed by postdoctoral training with Anne Eichmann in vascular biology and angiogenesis. This dual expertise enables her unique perspective on neurovascular crosstalk. Brunet's research centers on deciphering how neuronal and vascular systems interact during development and in pathological conditions. Her work explores guidance mechanisms (e.g., Ephrin-A4/EphA4, Netrin-1), arterial innervation dynamics, and lymphatic-vascular interactions, with significant implications for understanding chemotherapy-induced neuropathies and vascular disorders. She employs cutting-edge methodologies including tissue-clearing 3D imaging and functional assays to visualize neurovascular interfaces at cellular resolution. Analysis of her 2014-2022 publications reveals consistent advancement in understanding neurovascular patterning, with particular emphasis on sympathetic innervation of arteries, perivascular macrophage heterogeneity, and Schwann cell-vascular interactions. Her work bridges fundamental developmental biology with translational applications in neuropathic pain and vascular pathologies. Brunet actively contributes to scientific governance through evaluations for Inserm CSS, HCERES, Doctoral Schools, and journal/grant reviews. Her leadership extends to mentoring her research team and disseminating findings through publications and presentations. The Molecular Control of Neurovascular Development laboratory at CIRB operates as a dynamic interdisciplinary hub where neuroscientists, vascular biologists, and imaging specialists collaborate using transgenic models and advanced microscopy to unravel neurovascular communication mechanisms. Current projects focus on functional consequences of neurovascular mispatterning in disease contexts.

Eva Liebauمشاهده پروفایل

استاد

• Glutathione metabolism
• Oxidative stress response
• Parasitic nematodes
• +۵ مورد دیگر

Prof. Dr. Eva Liebau is a Professor and Group Leader at the Institute for Integrative Cell Biology and Physiology, University of Münster, Germany, specializing in Molecular Physiology. She leads an active research group investigating glutathione metabolism, oxidative stress response, and parasitic nematodes, with significant involvement in the SãMBio German-Brazilian double degree program with the University of São Paulo. Her research focuses on the molecular mechanisms of genetic adaptation to xenobiotic compounds and oxidative stressors, using Caenorhabditis elegans as a model organism. Her work spans environmental stress response, thiol-based redox signaling, glutathione-related enzymes, regulation of translation, and the secretome of parasitic nematodes. She has made significant contributions to understanding the UFM1 cascade, a posttranslational modification system highly conserved in multicellular organisms. Prof. Liebau's recent publications reveal a strong trend toward anthelmintic drug discovery using natural compounds and plant extracts, with particular emphasis on understanding the mechanisms of action against parasitic nematodes. Her work bridges basic molecular research with applied parasitology, contributing to both fundamental understanding of stress responses and potential therapeutic applications. She actively supervises PhD and MSc students including Emma Schröder and Luka Ressmann, and collaborates extensively with international partners including the Institute of Biomedical Sciences at the University of São Paulo, the Institute of Pharmaceutical Biology and Phytochemistry at the University of Münster, and the Redox Homeostasis Group at the Institute of Biomedicine of Seville. Prof. Liebau is affiliated with multiple research networks including Cells in Motion, CRC 1009 (Breaking Barriers), CRC 1348 (Dynamic Cellular Interfaces), CRC 1459 (Intelligent Matter), and CRC 944 (Physiology and Dynamics of Cellular Microcompartments), and participates in several PhD programs including CiM-IMPRS, IRTG Graduate School, and SP BioSciences.

• Pediatric Cardiology
• Echocardiography
• Cardiac Mechanics
• +۴ مورد دیگر

Murat Deveci is an Associate Professor of Pediatric Cardiology at Kocaeli University School of Medicine, with extensive clinical and research activities spanning pediatric cardiovascular diseases, echocardiography, and cardiac complications in systemic disorders. His work integrates clinical practice with advanced diagnostic techniques including speckle tracking echocardiography. His primary research interests focus on pediatric cardiac mechanics , Kawasaki disease complications , cardiovascular risk in chronic kidney disease , and early markers of atherosclerosis in hypertensive children . He utilizes advanced echocardiographic techniques to detect subclinical cardiac involvement in conditions like celiac disease, lupus, and obesity. Analysis of his 15 most recent publications reveals strong emphasis on translational research connecting basic cardiac mechanics with clinical outcomes , particularly in vulnerable pediatric populations including cancer survivors, CKD patients, and those with autoimmune disorders. His work frequently addresses diagnostic challenges in rare cardiac pathologies. Temel Ekokardiyografi Kursu Birinciligi (Basic Echocardiography Course First Place), 2012 Sahra Sihhiye Okulu 306. Dönem Astegmen Kursu Ikinciligi (Desert Sanitary School Cadet Course Second Place), 2005 Deveci actively mentors numerous junior researchers including Babaoglu, Kayabey Colak, and Tugral, with collaborative work extending to cardiovascular complications in genetic syndromes and inflammatory conditions. His research often involves multicenter collaborations addressing critical gaps in pediatric cardiovascular risk stratification.

• Physical Medicine and Rehabilitation
• Osteoporosis
• Joint Hypermobility and Ehlers-Danlos Syndrome
• +۷ مورد دیگر

Derya DEMİRBAĞ KABAYEL is a Professor at Trakya University Medical Faculty, Department of Physical Medicine and Rehabilitation since 2015. She holds a Doctoral degree obtained in 2003 and has established herself as a prominent researcher in rehabilitation medicine with a focus on multiple specialized areas. Her primary research interests include: Physical Medicine and Rehabilitation protocols Osteoporosis and bone mineral density assessment Joint hypermobility and Ehlers-Danlos Syndrome Parkinson's Disease rehabilitation Pulmonary rehabilitation, particularly related to post-COVID-19 recovery Cardiac rehabilitation and exercise physiology Her publication record demonstrates expertise in developing rehabilitation guidelines, particularly for post-COVID-19 patients, with numerous articles addressing pulmonary rehabilitation principles for acute, subacute, and long-term recovery phases. Her work on Parkinson's rehabilitation compares different exercise modalities including cycle ergometry versus body weight-supported treadmill training. Her research on joint hypermobility spans genetic factors, cardiovascular associations like mitral valve prolapse, and potential biomarkers for Ehlers-Danlos Syndromes. She has also contributed significantly to understanding the relationship between exercise capacity and psychological factors in cardiac rehabilitation. Professor Kabayel has served as a referee for multiple prestigious journals including Turkish Journal of Physical Medicine and Rehabilitation, Archives of Rheumatology, and Balkan Medical Journal. She has participated extensively in national and international conferences, often as a speaker, session chair, or course instructor on topics ranging from lymphedema management to cardiac rehabilitation for spinal cord injury patients. She has advised doctoral dissertations focusing on Parkinson's disease rehabilitation approaches and has participated in various research projects examining multifidus muscle relationships with postural sway, Parkinson's rehabilitation, and gene expression in joint hypermobility cases.

Carrie Wieseمشاهده پروفایل

استادیار

• Cardiometabolic physiology
• Sex differences in disease
• Genetic sex impact on physiology
• +۴ مورد دیگر

Dr. Carrie Wiese is an Assistant Professor in the Department of Pharmacology at the LSU Health Sciences Center School of Medicine in New Orleans, Louisiana. Her research focuses on the impact of sex components—gonads and sex chromosomes—on cardiometabolic physiology, with particular emphasis on how genetic sex influences disease mechanisms. Education: Postdoctoral Fellowship in Human Genetics, University of California, Los Angeles (2024) Ph.D. in Molecular Physiology & Biophysics, Vanderbilt University (2019) B.S. in Molecular Biology, University of Tennessee, Chattanooga (2008) Dr. Wiese's research investigates how the sex chromosome complement (XX and XY) causes unequal gene dosage through two mechanisms: 1) the presence and absence of Y chromosome genes and 2) a subset of X chromosome genes escaping X chromosome inactivation, leading to higher expression in XX cells than XY cells. These mechanisms modulate cellular function and impact whole-body physiology. Her current research projects include utilizing multi-omics approaches to assess the impact of gonadal and genetic sex on hepatic function during fatty liver disease, evaluating the impact of sex on epigenetic regulation in atherosclerosis, and determining the role of X chromosome gene Kdm6a in brown adipose energy metabolism. Dr. Wiese has published extensively on sex differences in cardiometabolic disease, with recent publications focusing on X chromosome dosage effects, sex differences in lipid metabolism, and the role of specific genes in sex-biased disease phenotypes. Her work bridges basic genetic mechanisms with clinical implications for understanding sex differences in disease susceptibility and treatment response. Scientific Awards: No specific awards mentioned in the provided text Dr. Wiese is actively mentoring graduate students and post-doctoral fellows in her laboratory. Her research has significant implications for understanding sex differences in disease mechanisms and developing more personalized approaches to treating cardiometabolic disorders. She is currently accepting new graduate students and post-doctoral fellows to join her research team. Dr. Wiese's laboratory is part of the Cardiovascular Center at LSU Health Sciences Center, where she collaborates with other researchers investigating cardiovascular disease mechanisms and potential therapeutic approaches.

John A. Lincolnمشاهده پروفایل

استاد

• Multiple Sclerosis
• Neuroimmunology
• Neurodegeneration
• +۷ مورد دیگر

John A. Lincoln, MD, PhD is a Professor of Neurology at The University of Texas Health Science Center at Houston (UTHealth), where he serves as Director of the MRI Analysis Center and Co-Director of the Neurology Residency Program. He joined the Multiple Sclerosis research group at UTHealth in 2011 after previously serving on the faculty at the University of Medicine and Dentistry of New Jersey (UMDNJ) from 2008-2011. Dr. Lincoln earned his Bachelor of Science in Genetics from Texas A&M University in 1992, followed by a Master's in Microbiology and PhD in Immunology from Texas Tech University. He completed his medical degree at Texas Tech University Health Sciences Center in 2002, followed by a Neurology residency at UT Health Science Center at Houston and a Neuroimmunology fellowship at UMDNJ. His research focuses on neurodegenerative processes in multiple sclerosis, with particular emphasis on glymphatic system dysfunction, cerebrovascular reactivity, spinal cord evaluation, and bladder-related neurological complications. Recent publications demonstrate his integration of advanced MRI techniques with machine learning approaches to predict disease severity and understand MS pathology. Analysis of his publication record from 2008-2024 reveals a consistent research trajectory focused on MS mechanisms and clinical manifestations, with increasing emphasis on neuroimaging biomarkers and computational approaches in recent years. His work spans clinical neurology, neuroimmaging, immunology, and rehabilitation aspects of MS. As Director of the MRI Analysis Center, Dr. Lincoln oversees advanced neuroimaging research and clinical applications. His leadership in the Neurology Residency Program demonstrates his commitment to training the next generation of neurologists specializing in complex neurological disorders. Dr. Lincoln's clinical expertise includes diagnosing and managing multiple sclerosis and immune-mediated neurological disorders, with special attention to neurological complications such as bladder dysfunction and trigeminal neuralgia in MS patients. His multidisciplinary approach bridges basic science discoveries with clinical applications to improve patient outcomes.

Eva Sevick-Muracaمشاهده پروفایل

استاد

• Molecular Imaging
• Near-infrared fluorescence optical imaging
• Tomography
• +۵ مورد دیگر

Dr. Eva Sevick-Muraca is a Professor and the Nancy and Rich Kinder Distinguished Chair of Cardiovascular Disease Research at the University of Texas Health Science Center's Institute of Molecular Medicine (IMM), where she directs the Center for Molecular Imaging. She also leads the National Cancer Institute Center for Translational Research at the IMM, focusing on the development and validation of new imaging instrumentation, algorithms, and imaging agents for clinical translation. Dr. Sevick-Muraca's research expertise spans multiple cutting-edge areas in biomedical imaging: Pioneering development of near-infrared fluorescence optical imaging and tomography Diagnostic imaging of lymphatic function Nodal staging in cancer Preclinical small animal imaging with nuclear and optical techniques Clinical translation of imaging technologies Cardiovascular disease imaging applications Her scientific achievements have been recognized with prestigious awards: National Science Foundation Young Investigator Award National Institutes of Health Research Career Award American Cancer Society Research Scholar Award Dr. Sevick-Muraca has built a distinguished career across multiple institutions, having held faculty positions at Vanderbilt University, Purdue University, Texas A&M University, and Baylor College of Medicine before joining the University of Texas Health Science Center. She has contributed significantly to the scientific community through service roles including membership on the Biomedical Imaging Study section, associate editorship of IEEE Transactions of Medical Imaging, and leadership positions in the Society of Molecular Imaging. Her educational foundation includes a Ph.D. in Chemical Engineering from Carnegie Mellon University and post-doctoral training in Biochemistry and Biophysics at the University of Pennsylvania.

Judy L. Thomasمشاهده پروفایل

استادیار بالینی

• Physical Medicine and Rehabilitation
• Musculoskeletal Rehabilitation
• Spasticity Management
• +۳ مورد دیگر

Dr. Judy L. Thomas is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation (PM&R) at McGovern Medical School, part of The University of Texas Health Science Center at Houston (UTHealth). She serves as Chief of PM&R at Lyndon Baines Johnson General Hospital, a position she has held since 2011 when she joined the UTHealth faculty. Dr. Thomas earned her medical degree from the University of Toronto in 2004, completed residency training in PM&R at McMaster University in 2009, and finished a fellowship in Brain Injury and Spasticity Management at Baylor College of Medicine in 2011. Her clinical expertise spans General Physiatry with special interests in Musculoskeletal Rehabilitation and Spasticity Management. Her research has evolved significantly over the past decade, with recent focus on meningeal lymphatic system function and its relationship to neurological conditions. Dr. Thomas has made important contributions to understanding how lymphatic drainage affects neuroinflammation, brain tumor immunosurveillance, and neural repair processes. Her work bridges clinical rehabilitation medicine with cutting-edge neuroscience and immunology research. Analysis of her publication record from 2010-2024 shows a progression from clinical guidelines in physical medicine to sophisticated investigations of the meningeal lymphatic system. Her most recent work (2023-2024) explores specialized lymphatic circuits including ocular systems and CSF-to-dura gateways, demonstrating increasing specialization in neurolymphatic interactions. Dr. Thomas maintains an active research program with multiple publications in high-impact journals including Nature, Immunity, and Journal of Experimental Medicine. Her collaborative approach is evident in her numerous co-authorships with researchers across disciplines including neuroscience, immunology, and vascular biology. As both a clinician and researcher, Dr. Thomas provides valuable mentorship opportunities for students interested in translational research at the intersection of rehabilitation medicine, neurology, and immunology. Her dual roles enable her to connect basic science discoveries with clinical applications in patient care.

Franklyn Howeمشاهده پروفایل

استاد

• Magnetic Resonance Imaging
• Medical Diagnostics
• Neuroimaging
• +۵ مورد دیگر

Professor Franklyn Howe serves as Professor of Magnetic Resonance Imaging and Director of the Neuroscience & Cell Biology Research Institute at City St George's, University of London (formed from the August 2024 merger of St George's, University of London and City University of London). With a career spanning since 1988 at St George's, he has established himself as a leading expert in multimodal MRI applications for disease diagnosis and treatment monitoring, particularly in brain tumor analysis. His work bridges physics, medical imaging, and clinical applications across multiple disease areas. Professor Howe earned his BA in Physics from the University of Oxford, followed by a DPhil on 'Magnetisation and microwave absorption in rare earth metal alloys' from the same institution in 1984. He completed postdoctoral research evaluating MRI contrast agents at St Bartholomew's Hospital and in MR image analysis at the Royal Postgraduate Medical School (now part of Imperial College School of Medicine) before joining St George's. Howe's research centers on developing automated analysis of multimodal MRI to aid diagnosis of brain tumors, using various MRI methods including perfusion and diffusion imaging for structural and functional information, and magnetic resonance spectroscopy (MRS) for biochemical data. He applies pattern recognition techniques to optimally combine data from different MRI methods, aiming to develop biomarkers for diagnosis, prognosis assessment, and treatment response monitoring. His work extends beyond brain tumors to dementia, Tourette syndrome, cerebrovascular disease, chronic obstructive pulmonary disease, lupus, lymphedema, osteoarthritis, and normal aging. In 1992, he was instrumental in developing MR Neurography at St George's, a non-invasive method for detailed nerve imaging. Analysis of Professor Howe's recent publications (2021-2024) reveals consistent focus on advancing MRI techniques across multiple clinical applications. His work demonstrates strong interdisciplinary collaboration, with significant contributions to lymphatic imaging, brain tumor characterization, neurodegenerative disorders, and quantitative MRI methodology. The publications show progression from fundamental technical improvements in MRI acquisition and processing toward increasingly sophisticated clinical applications, particularly in neuroimaging and vascular disorders. Chair of ISMRM MRS Study Group Co-founder and Chair of Pediatric MR Study Group Long-standing member of International Society of Magnetic Resonance in Medicine Professor Howe actively supervises lab-based MRes and BSc student research projects and library-based Special Study Courses on Biomedical Applications of Magnetic Resonance. He has secured substantial research funding from diverse sources including the Medical Research Council, Cancer Research UK, Alzheimer's Research UK, and St George's Hospital Charity. His collaborative approach is evident in the wide range of clinical research studies he participates in across multiple departments. As Director of the Neuroscience & Cell Biology Research Institute, Howe leads a research team including Ian Storey (Image Analyst) and Mike Mills (MRI physicist). He maintains extensive collaborations within St George's with Dr Thomas Barrick, Dr Atticus Hainsworth, Mr Timothy Jones (Neurosurgery), Dr Jeremy Isaacs (Neurology), Dr Pia Ostergaard, Prof Sahar Mansour (Clinical Genetics), Prof Nidhi Sofat (Rheumatology), and Mr Michael Hart (Neurosurgery), creating a robust interdisciplinary research environment focused on translating MRI advances into clinical practice.

• Pediatric Hematology
• Pediatric Thrombosis
• Pediatric Anticoagulation
• +۳ مورد دیگر

Joel Livingston serves as an Assistant Professor in the Department of Pediatrics within the Faculty of Medicine & Dentistry at the University of Alberta, where he practices as a Pediatric Hematologist and leads the KidClot Program at Stollery Children's Hospital. His clinical and research focus centers on advancing hematologic and thrombotic care for pediatric patients through quality improvement initiatives and patient-centered outcomes research. Dr. Livingston's scholarly work demonstrates deep expertise in pediatric immune thrombocytopenia, anticoagulation management, and thrombosis prevention. His research consistently prioritizes patient quality of life while addressing critical gaps in pediatric hematology protocols. Current investigations include optimizing anticoagulant dosing regimens, evaluating thrombopoietin receptor agonists, and developing innovative care models for children with clotting disorders. Analysis of his 15 most recent publications (2014-2025) reveals a cohesive research trajectory centered on translational hematology. His work spans clinical trials, retrospective analyses, and case studies addressing pediatric-specific challenges in thrombosis management, with recurring themes of protocol optimization, adherence interventions, and quality-of-life assessment in chronic hematologic conditions. As Medical Lead of the KidClot Program, Dr. Livingston directs clinical and research activities focused on evidence-based thrombosis care for children. The program serves as a hub for multidisciplinary collaboration in developing and implementing best practices for pediatric anticoagulation and thromboprophylaxis across Alberta.

Indunil Karunarathnaمشاهده پروفایل

استاد بالینی

• Anaesthesiology
• Critical Care
• Pain Medicine
• +۷ مورد دیگر

Dr. Indunil Karunarathna is a Consultant Anaesthesiologist affiliated with the Faculty of Medicine at University of Colombo, Sri Lanka, currently serving at Teaching Hospital Polonnaruwa under the Ministry of Health, Sri Lanka. He maintains additional clinical connections with Teaching Hospital Badulla and holds postdoctoral status in his field. His research interests span a remarkable breadth of medical specialties including Anaesthesiology, Critical Care, Pain Medicine, Intensive Care Medicine, Emergency Medicine, Urology, Ophthalmology, Gynecology, and Burn Surgery. His scholarly work consistently emphasizes interdisciplinary approaches to patient care, reflecting his commitment to comprehensive medical practice. Dr. Karunarathna's publication record demonstrates significant contributions across multiple medical domains, with particular focus on diagnostic precision, evidence-based therapeutic interventions, and complication prevention. His work frequently addresses the integration of advanced technologies and interprofessional collaboration in optimizing patient outcomes. Specializes in complex diagnostic challenges across multiple medical specialties Focuses on evidence-based therapeutic interventions and complication prevention Emphasizes interdisciplinary approaches to patient management Publishes on emerging diagnostic technologies and treatment paradigms His scholarly contributions reflect both clinical expertise and academic rigor, with publications addressing everything from rare genetic disorders to common clinical presentations, always with emphasis on practical clinical application and patient-centered care.